Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

2009
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2020 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

2 results

Results by year

Filters applied: . Clear all
Page 1
ER membranes associated with mitochondria: Possible therapeutic targets in heart-associated diseases.
Silva-Palacios A, Zazueta C, Pedraza-Chaverri J. Silva-Palacios A, et al. Pharmacol Res. 2020 Jun;156:104758. doi: 10.1016/j.phrs.2020.104758. Epub 2020 Mar 18. Pharmacol Res. 2020. PMID: 32200027 Review.
In this review, we highlight MAMs' alterations mainly in cardiomyocytes, linked with cardiovascular diseases, such as cardiac ischemia-reperfusion, heart failure, and dilated cardiomyopathy. We also describe proteins that are part of the MAMs' machinery, as the FUN1 …
In this review, we highlight MAMs' alterations mainly in cardiomyocytes, linked with cardiovascular diseases, such as cardiac ischemia-reper …
Emerging cardiovascular actions of the incretin hormone glucagon-like peptide-1: potential therapeutic benefits beyond glycaemic control?
Grieve DJ, Cassidy RS, Green BD. Grieve DJ, et al. Br J Pharmacol. 2009 Aug;157(8):1340-51. doi: 10.1111/j.1476-5381.2009.00376.x. Br J Pharmacol. 2009. PMID: 19681866 Free PMC article. Review.
GLP-1 receptors (GLP-1Rs) are expressed in the heart and vasculature of both rodents and humans, and recent studies have demonstrated that GLP-1R agonists have wide-ranging cardiovascular actions, such as modulation of heart rate, blood pressure, vascular tone and myocardi …
GLP-1 receptors (GLP-1Rs) are expressed in the heart and vasculature of both rodents and humans, and recent studies have demonstrated that G …